Epigenomics AG (FRA:ECX)

Germany flag Germany · Delayed Price · Currency is EUR
0.8500
-0.0100 (-1.16%)
Last updated: Jul 16, 2025
43.10%
Market Cap754.18K
Revenue (ttm)n/a
Net Income (ttm)-3.35M
Shares Out876.95K
EPS (ttm)-3.82
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volumen/a
Average Volume1,821
Open0.8500
Previous Close0.8600
Day's Range0.8500 - 0.8500
52-Week Range0.5000 - 2.3000
Beta1.05
RSI60.86
Earnings DateJul 30, 2025

About Epigenomics AG

Epigenomics AG does not have significant operations. Previously, it was involved in liquid biopsy for the early detection of cancer. The company was founded in 1998 and is based in Heidelberg, Germany. [Read more]

Industry In Vitro and In Vivo Diagnostic Substances
Founded 1998
Employees 2
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol ECX
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.